A look at the upper heart chamber: The left atrium in chronic kidney disease

Nephrology Dialysis Transplantation

Volumn 29, Issue 10, 2014, Pages 1847-1853

  Paoletti, Ernesto ^a   Zoccali, Carmine ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b CNR Consiglio Nazionale delle Ricerche   (Italy)

Author keywords

cardiomyopathy; CKD; clinical outcome; diastolic function; left atrium

Indexed keywords

C REACTIVE PROTEIN;

ADVERSE OUTCOME; ATRIAL FIBRILLATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CHRONIC KIDNEY DISEASE; DISEASE MARKER; END STAGE RENAL DISEASE; HEART ATRIUM ENLARGEMENT; HEART LEFT ATRIUM; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEMODIALYSIS; HUMAN; INFLAMMATION; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; MORTALITY; NONHUMAN; PATHOPHYSIOLOGY; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; CARDIOVASCULAR DISEASES; CHRONIC KIDNEY FAILURE; COMPLICATION; DISEASE COURSE; HEART ATRIUM; HEART LEFT VENTRICLE FUNCTION; PATHOLOGY; RISK FACTOR;

CARDIOVASCULAR DISEASES; DISEASE PROGRESSION; HEART ATRIA; HUMANS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84921768237     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gft482     Document Type: Review

References (77)

1. Zoccali C. How important is echocardiography for risk stratification in follow-up of patients with chronic kidney disease? Nat Clin Pract Nephrol 2007; 3: 178-179
2. Park M, Hsu CY, Li Y et al. Associations between kidney function and subclinical cardiac abnormalities in CKD. J Am Soc Nephrol 2012; 23: 1725-1734
3. Levin A. Clinical epidemiology of cardiovascular disease in chronic kidney disease prior to dialysis. Semin Dial 2003; 16: 101-105
4. Zoccali C, Benedetto FA, Mallamaci F et al. Prognostic impact of the indexation of left ventricular mass in patients undergoing dialysis. J Am Soc Nephrol 2001; 12: 2768-2774
5. Amann K, Rychlik I, Miltenberger-Milteny G et al. Left ventricular hypertrophy in renal failure. Kidney Int Suppl 1998; 68: S78-S85
6. Pizzarelli F, Dattolo P, Ferdeghini EM et al. Parameters derived by ultrasonic myocardial characterization in dialysis patients are associated with mortality. Kidney Int 2005; 68: 1320-1325
7. Salvetti M, Muiesan ML, Paini A et al. Myocardial ultrasound tissue characterization in patients with chronic renal failure. J Am Soc Nephrol 2007; 18: 1953-1958
8. Redfield MM, Jacobsen SJ, Burnett JC, Jr et al. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 2003; 289: 194-202
9. Meyer T, Shih J, Aurigemma G. Heart failure with preserved ejection fraction (diastolic dysfunction). Ann Intern Med 2013; 158: ITC5
10. Pecoits-Filho R, Bucharles S, Barberato SH. Diastolic heart failure in dialysis patients: mechanisms, diagnostic approach, and treatment. Semin Dial 2012; 25: 35-41
11. Tsang TS, Barnes ME, Gersh BJ et al. Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am J Cardiol 2002; 90: 1284-1289
12. Rossi A, Temporelli PL, Quintana M et al. Independent relationship of left atrial size and mortality in patients with heart failure: an individual patient meta-analysis of longitudinal data (MeRGE Heart Failure). Eur J Heart Fail 2009; 11: 929-936
13. Abhayaratna WP, Seward JB, Appleton CP et al. Left atrial size: physiologic determinants and clinical applications. J Am Coll Cardiol 2006; 47: 2357-2363
14. Appleton CP, Galloway JM, Gonzalez MS et al. Estimation of left ventricular filling pressures using two-dimensional and Doppler echocardiography in adult patients with cardiac disease. Additional value of analyzing left atrial size, left atrial ejection fraction and the difference in duration of pulmonary venous and mitral flow velocity at atrial contraction. J Am Coll Cardiol 1993; 22: 1972-1982
15. Basnight MA, Gonzalez MS, Kershenovich SC et al. Pulmonary venous flow velocity: relation to hemodynamics, mitral flow velocity and left atrial volume, and ejection fraction. J Am Soc Echocardiogr 1991; 4: 547-558
16. Lang RM, Bierig M, Devereux RB et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18: 1440-1463
17. Douglas PS. The left atrium: a biomarker of chronic diastolic dysfunction and cardiovascular disease risk. J Am Coll Cardiol 2003; 42: 1206-1207
18. Agarwal R, Bouldin JM, Light RP et al. Inferior vena cava diameter and left atrial diameter measure volume but not dry weight. Clin J Am Soc Nephrol 2011; 6: 1066-1072
19. Ozkahya M, Ok E, Cirit M et al. Regression of left ventricular hypertrophy in haemodialysis patients by ultrafiltration and reduced salt intake without antihypertensive drugs. Nephrol Dial Transplant 1998; 13: 1489-1493
20. Whalley GA, Marwick TH, Doughty RN et al. Effect of early initiation of dialysis on cardiac structure and function: results from the echo substudy of the IDEAL trial. Am J Kidney Dis 2013; 61: 262-270
21. Tripepi G, Benedetto FA, Mallamaci F et al. Left atrial volume in endstage renal disease: a prospective cohort study. J Hypertens 2006; 24: 1173-1180
22. Tripepi G, Mattace-Raso F, Mallamaci F et al. Biomarkers of left atrial volume: a longitudinal study in patients with end stage renal disease. Hypertension 2009; 54: 818-824
23. Essig M, Escoubet B, de Zuttere D et al. Cardiovascular remodelling and extracellular fluid excess in early stages of chronic kidney disease. Nephrol Dial Transplant 2008; 23: 239-248
24. Barnes ME, Miyasaka Y, Seward JB et al. Left atrial volume in the prediction of first ischemic stroke in an elderly cohort without atrial fibrillation. Mayo Clin Proc 2004; 79: 1008-1014
25. Castiglioni P, Parati G, Brambilla L et al. Detecting sodium-sensitivity in hypertensive patients: information from 24-hour ambulatory blood pressure monitoring. Hypertension 2011; 57: 180-185
26. Covic A, Goldsmith DJ, Covic M. Reduced blood pressure diurnal variability as a risk factor for progressive left ventricular dilatation in hemodialysis patients. Am J Kidney Dis 2000; 35: 617-623
27. Rao AK, Djamali A, Korcarz CE et al. Left atrial volume is associated with inflammation and atherosclerosis in patients with kidney disease. Echocardiography 2008; 25: 264-269
28. Psychari SN, Apostolou TS, Sinos L et al. Relation of elevated C-reactive protein and interleukin-6 levels to left atrial size and duration of episodes in patients with atrial fibrillation. Am J Cardiol 2005; 95: 764-767
29. Xu J, Cui G, Esmailian F et al. Atrial extracellular matrix remodeling and the maintenance of atrial fibrillation. Circulation 2004; 109: 363-368
30. Frustaci A, Caldarulo M, Buffon A et al. Cardiac biopsy in patients with 'primary' atrial fibrillation. Histologic evidence of occult myocardial diseases. Chest 1991; 100: 303-306
31. Kursat S, Tekce H, Ekmekci C et al. Relationship between the degree of malnutrition and echocardiographic parameters in hemodialysis patients. Nephron Clin Pract 2007; 106: c136-c142
32. Ikizler TA, Cano NJ, Franch H et al. Prevention and treatment of protein energy wasting in chronic kidney disease patients: a consensus statement by the International Society of Renal Nutrition and Metabolism. Kidney Int 2013; doi: 10.1038/ki.2013.147
33. Dumler F. Hypoalbuminemia is a marker of overhydration in chronic maintenance patients on dialysis. ASAIO J 2003; 49: 282-286
34. Vicente-Martinez M, Martinez-Ramirez L, Munoz R et al. Inflammation in patients on peritoneal dialysis is associated with increased extracellular fluid volume. Arch Med Res 2004; 35: 220-224
35. Schulz R, Heusch G. C-reactive protein: just a biomarker of inflammation or a pathophysiological player in myocardial function and morphology? Hypertension 2011; 57: 151-153
36. Genovesi S, Pogliani D, Faini A et al. Prevalence of atrial fibrillation and associated factors in a population of long-term hemodialysis patients. Am J Kidney Dis 2005; 46: 897-902
37. Wang AY, Lu Y, Cheung S et al. Plasma sodium and subclinical left atrial enlargement in chronic kidney disease. Nephrol Dial Transplant 2013; 28: 2319-2328
38. Kovesdy CP, Lott EH, Lu JL et al. Hyponatremia, hypernatremia, and mortality in patients with chronic kidney disease with and without congestive heart failure. Circulation 2012; 125: 677-684
39. Kovesdy CP. Significance of hypo-and hypernatremia in chronic kidney disease. Nephrol Dial Transplant 2012; 27: 891-898
40. Mallamaci F, Tripepi G. Salt and the heart in chronic kidney disease: an atrial connection. Nephrol Dial Transplant 2013; 28: 2210-2211
41. Lonborg JT, Engstrom T, Moller JE et al. Left atrial volume and function in patients following ST elevation myocardial infarction and the association with clinical outcome: a cardiovascular magnetic resonance study. Eur Heart J Cardiovasc Imaging 2013; 14: 118-127
42. Tani T, Tanabe K, Ono M et al. Left atrial volume and the risk of paroxysmal atrial fibrillation in patients with hypertrophic cardiomyopathy. J Am Soc Echocardiogr 2004; 17: 644-648
43. Moller JE, Hillis GS, Oh JK et al. Left atrial volume: a powerful predictor of survival after acute myocardial infarction. Circulation 2003; 107: 2207-2212
44. Beinart R, Boyko V, Schwammenthal E et al. Long-term prognostic significance of left atrial volume in acute myocardial infarction. J Am Coll Cardiol 2004; 44: 327-334
45. Losi MA, Betocchi S, Aversa M et al. Determinants of atrial fibrillation development in patients with hypertrophic cardiomyopathy. Am J Cardiol 2004; 94: 895-900
46. Gerdts E, Wachtell K, Omvik P et al. Left atrial size and risk of major cardiovascular events during antihypertensive treatment: losartan intervention for endpoint reduction in hypertension trial. Hypertension 2007; 49: 311-316
47. Gupta S, Matulevicius SA, Ayers CR et al. Left atrial structure and function and clinical outcomes in the general population. Eur Heart J 2013; 34: 278-285
48. Patel DA, Lavie CJ, Milani RV et al. Left atrial volume index predictive of mortality independent of left ventricular geometry in a large clinical cohort with preserved ejection fraction. Mayo Clin Proc 2011; 86: 730-737
49. Tripepi G, Benedetto FA, Mallamaci F et al. Left atrial volume monitoring and cardiovascular risk in patients with end-stage renal disease: a prospective cohort study. J Am Soc Nephrol 2007; 18: 1316-1322
50. Patel RK, Jardine AG, Mark PB et al. Association of left atrial volume with mortality among ESRD patients with left ventricular hypertrophy referred for kidney transplantation. Am J Kidney Dis 2010; 55: 1088-1096
51. Ozdogan O, Kayikcioglu M, Asci G et al. Left atrial volume predicts mortality in low-risk dialysis population on long-term low-salt diet. Am Heart J 2010; 159: 1089-1094
52. Kim SJ, Han SH, Park JT et al. Left atrial volume is an independent predictor of mortality in CAPD patients. Nephrol Dial Transplant 2011; 26: 3732-3739
53. Chan MY, Wong HB, Ong HY et al. Prognostic value of left atrial size in chronic kidney disease. Eur J Echocardiogr 2008; 9: 736-740
54. Chen SC, Chang JM, Liu WC et al. Echocardiographic parameters are independently associated with increased cardiovascular events in patients with chronic kidney disease. Nephrol Dial Transplant 2012; 27: 1064-1070
55. Bolignano D, Rastelli S, Agarwal R et al. Pulmonary hypertension in CKD. Am J Kidney Dis 2013; 61: 612-622
56. Tripepi G, Pannier B, Mallamaci F et al. Left ventricular mass is a powerful risk factor for all-cause and cardiovascular death in end stage kidney disease patients but does not contribute to prognosis: an analysis in two European cohorts. In: 50th ERA-EDTA Congress, Istanbul, 18-21 May 2013
57. Ananthapanyasut W, Napan S, Rudolph EH et al. Prevalence of atrial fibrillation and its predictors in nondialysis patients with chronic kidney disease. Clin J Am Soc Nephrol 2010; 5: 173-181
58. Vazquez E, Sanchez-Perales C, Garcia-Garcia F et al. Atrial Fibrillation in incident dialysis patients. Kidney Int 2009; 76: 324-330
59. van Dokkum RP, Eijkelkamp WB, Kluppel AC et al. Myocardial infarction enhances progressive renal damage in an experimental model for cardiorenal interaction. J Am Soc Nephrol 2004; 15: 3103-3110
60. Zoccali C, Goldsmith D, Agarwal R et al. The complexity of the cardiorenal link: taxonomy, syndromes, and diseases. Kidney Int Suppl 2011; 1: 2-5
61. Paoletti E. Left ventricular hypertrophy and progression of chronic kidney disease. J Nephrol 2012; 25: 847-850
62. Tsioufis C, Kokkinos P, Macmanus C et al. Left ventricular hypertrophy as a determinant of renal outcome in patients with high cardiovascular risk. J Hypertens 2010; 28: 2299-2308
63. Ravera M, Noberasco G, Signori A et al. Left-ventricular hypertrophy and renal outcome in hypertensive patients in primary-care. Am J Hypertens 2013; 26: 700-707
64. Paoletti E, Bellino D, Gallina AM et al. Is left ventricular hypertrophy a powerful predictor of progression to dialysis in chronic kidney disease? Nephrol Dial Transplant 2011; 26: 670-677
65. Chen SC, Su HM, Hung CC et al. Echocardiographic parameters are independently associated with rate of renal function decline and progression to dialysis in patients with chronic kidney disease. Clin J Am Soc Nephrol 2011; 6: 2750-2758
66. Furukawa M, Io H, Tanimoto M et al. Predictive factors associated with the period of time before initiation of hemodialysis in CKD stages 4 and 5. Nephron Clin Pract 2011; 117: c341-c347
67. Kim SJ, Oh HJ, Yoo DE et al. Left atrial enlargement is associated with a rapid decline in residual renal function in ESRD patients on peritoneal dialysis. J Am Soc Echocardiogr 2012; 25: 421-427
68. Enia G, Mallamaci F, Benedetto FA et al. Long-term CAPD patients are volume expanded and display more severe left ventricular hypertrophy than haemodialysis patients. Nephrol Dial Transplant 2001; 16: 1459-1464
69. Kuno T, Matsumoto K. Clinical benefit of preserving residual renal function in patients after initiation of dialysis. Blood Purif 2004; 22(Suppl. 2): 67-71
70. Tripepi G, Jager KJ, Dekker FW et al. Statistical methods for the assessment of prognostic biomarkers (Part I): discrimination. Nephrol Dial Transplant 2010; 25: 1399-1401
71. Ruegg C, Tissot JD, Farmer P et al. Omics meets hypothesis-driven research. Partnership for innovative discoveries in vascular biology and angiogenesis. Thromb Haemost 2008; 100: 738-746
72. Culleton BF, Walsh M, Klarenbach SW et al. Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial. JAMA 2007; 298: 1291-1299
73. Svensson S, Menkes DB, Lexchin J. Surrogate outcomes in clinical trials: a cautionary tale. JAMA Intern Med 2013; 173: 611-612
74. Barberato SH, Mantilla DE, Misocami MA et al. Effect of preload reduction by hemodialysis on left atrial volume and echocardiographic Doppler parameters in patients with end-stage renal disease. Am J Cardiol 2004; 94: 1208-1210
75. Tsang TS, Barnes ME, Abhayaratna WP et al. Effects of quinapril on left atrial structural remodeling and arterial stiffness. Am J Cardiol 2006; 97: 916-920
76. Thadhani R, Appelbaum E, Pritchett Y et al. Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial. JAMA 2012; 307: 674-684
77. Tamez H, Zoccali C, Packham D et al. Vitamin D reduces left atrial volume in patients with left ventricular hypertrophy and chronic kidney disease. Am Heart J 2012; 164: 902-909